Bioentrepreneur

Receiving reimbursement for your product is just as important as receiving regulatory approval.

A solid understanding of the myriad IP issues faced by biotech startups is essential to the long-term viability of these companies.

An analysis of the behaviors that have best served life science entrepreneurs.

Young biotech firms have ample opportunity to raise cash, but they need to appear more robust in order to compete with existing companies that are vying for the same funds.

An AUTM survey shows that US technology transfer is thriving, but many small universities are having trouble commercializing their research.

A new report shows that attempts by the Dutch government to grow its biotech sector have produced fresh start-ups. But will they survive?

Critics say a new report's measurements are not consistent, but there are still valuable lessons to be learned from it.

Cindy Robbins-Roth, long a force in biotech publishing and consulting, reflects on her self-adopted mission to both nurture the growth of biotechnology and bring a little fun to the field.

Because French academic science has only recently become entrepreneurial, the challenge for technology transfer has been to market biotechnologies strongly to potential licensees and corporate sponsors.

By understanding the subtleties of term sheets, founders of companies receiving their first round of venture financing can avoid unwelcome surprises.

Who are the super financiers of biotechnology?

Bioentrepreneurs would do well to follow these basic tenets when preparing to ask venture capitalists for funding.

The European biotechnology industry looks set for a shake-up when 13 new countries join the European Union later this decade, according to a new survey by the European Commission.

Scotland's government has taken a proactive approach to boosting its biotech industry, and other countries can learn from the details.

A genomics research initiative begun in 1998 has helped foster the French biotechnology industry, but a government-sponsored audit suggests that some improvements would attract more start-ups to the country.

Spinning out a new company presents challenges for both the parent company and the new entity, but setting the right boundaries and expectations upfront can prevent later difficulties and maximize the value of the asset to both parties.

Partly art, partly science, good website design is important for fledgling biotech companies.

An overview of biotechnology entrepreneurship activities in the Asia-Pacific region, where the industry is colorful and diverse, and the development potential is enormous.

US states are slashing funds for biotechnology programs from their budgets, threatening the economic development of startup firms.

Monitor Group finds a single, large university would benefit the state's biotech industry as well as university researchers.